1) extensive small-cell lung cancer
广泛期小细胞肺癌
1.
Objective: To evaluate the efficacy and toxicity reactions of etoposide capsules in treatment of extensive small-cell lung cancer(SCLC).
目的:评价足叶乙甙胶囊治疗广泛期小细胞肺癌的临床疗效及毒副作用。
3) advanced small cell lung cancer (SCLC)
晚期小细胞肺癌
1.
Objective To observe the efficacy and safety of chemotherapy consisted of lobaplatin (LBP) combined with etoposide for patients with advanced small cell lung cancer (SCLC).
目的观察评价新一代铂类抗癌药物洛铂(LBP)联合足叶乙甙(VP-16)组成的LE方案治疗晚期小细胞肺癌(SCLC)的有效性和安全性。
4) advanced non-small cell lung cancer(NSCLC) and advanced small cell lung cancer(SCLC)
晚期非小细胞肺癌和晚期小细胞肺癌
5) Small cell lung cancer
小细胞肺癌
1.
Combination chemotherapy with irinotecan and cisplatin as second-line treatment for small cell lung cancer;
依立替康联合顺铂二线治疗小细胞肺癌
2.
Radio-chemotherapy for patients with limited-stage small cell lung cancer;
局限期小细胞肺癌的放化疗
3.
Relation between the level of TPS,NSE,CEA and β_2-mG in the serum and the biological behavior of small cell lung cancer;
血清TPS、NSE、CEA、β_2MG水平与小细胞肺癌生物学关系的探讨
6) SCLC
小细胞肺癌
1.
Abnormal Methylation of Mismatch Repair Genes MLH1 and MSH2 in Human SCLC Cell Line H446 under Hypoxic Condition;
缺氧状态下人小细胞肺癌H446细胞错配修复基因MLH1、MSH2异常甲基化的研究
2.
Objective The aim of this study is to evaluate the efficacy and safety of the irinotecan and cisplatin combination in relapsed advanced SCLC.
目的观察伊立替康联合顺铂方案治疗复治性晚期小细胞肺癌的疗效和安全性。
3.
Aim To evaluate the therapeutic efficiency of Ad-hTRAIL (the replication-defective adenovirus expressing recombinant human TRAIL gene) on human small cell lung cancer (SCLC) cell line H446 in vitro.
目的评价携带人TRAIL基因的腺病毒载体对人小细胞肺癌细胞株H446的基因治疗功效。
补充资料：大细胞未分化型肺癌
大细胞未分化型肺癌
large cell undifferentiated carcinoma of lung
是支气管肺癌的一种类型。由大小不一的多边形细胞组成，呈实体巢状排列。癌细胞核大，核仁大而明显，胞浆丰富。可发生在肺门附近或肺边缘的支气管。治疗以手术、放疗或化疗综合治疗。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条